Price

rebased to 0%

AMGN, solidADMA, dashed

AMGNAmgen Inc

461.49−3.55%· post 460.22

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

ADMAAdma Biologics, Inc.

13.21+26.03%· post 13.27

ClosedNov 5 '26

Mkt cap$2.3BRevenue$141MQ3 FY26Revenue$510MFY25

vs

Compare

ClosedNov 5 '26

AMGNAmgen Inc

vs

ADMAAdma Biologics, Inc.

461.49−3.55%post 460.22

Price

13.21+26.03%post 13.27

$249.0B

Mkt cap

$2.3B

Q3 FY26$10.4B

Revenue

$141MQ3 FY26

FY25$36.8B

Revenue

$510MFY25

AMGN compared with ADMA: revenue, margins and what each company keeps, and the suppliers and customers both name